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Both HfSC and PL-MSC met the minimum criteria for MSCs (Table 1).  Ironically, BM-MSC 
did not.  However, we have identified 507 genes that are expressed in HfSCs but not in BM-
MSCs or PL-MSCs, and 520 genes that were expressed in the MSC lineages but not the 
HfSCs. The most notable differences among HfSCs, BM- and PL-MSCs were observed in 
genes involved with neural development. All three stem cells do not express Oct-4, Sox-2, 
and Nanog – genes considered critical genes for embryonic stem cells (ESCs). Those 
uniquely expressed by the HfSCs included epiregulin, a gene required for sustained cell 
growth without senescence; several genes for early neural development (ROBO2, 
FRMPD4, PCDH9); genes associated with development of germline cells (LHX9 and 
IGF2BP3); genes for early neuroectodermal development (RSPO2 and ZIC1); genes for 
development of endodermal phenotypes (NKX6-1 and ONECUT1); and genes associated 
with cardiac development (TBX5). 
RNA-seq was performed on MASCs cultured in vitro in the laboratory. MASCs were isolated 
from the dermis layer of human foreskin (HfSC-2) and were tested at Passage (P) 20. We 
then compared the gene expression of the MASCs to databases of genes expressed by 
bone marrow-derived mesenchymal stem cells (BM-MSCs) and placenta-derived 
mesenchymal stem cells (PL-MSCs)2. Significant differences were found in the relative gene 
expressions of the PL-MSCs, BM-MSCs, and HfSCs. Previously published data have shown 
that differences in gene expression exist even between two families of MSCs2. The NIH 
Database for Annotation, Visualization and Integrated Discovery (DAVID) was used to 
perform gene functional annotation clustering, with default options and annotation 
categories. Specific studies of pathway enrichment were performed utilizing DAVID’s GO-
BG annotation (Gene Ontology- Biological Groupings)3.  
 
Given the differences in differentiation and reproductive potential, 
we hypothesize that MASCs have a unique gene expression 
profile in comparison to other adult stem cells, particularly 
MSCs.  
Stem cells are defined as undifferentiated cells with the capacity for both 
self-renewal and future differentiation. Importantly, stem cells can 
proliferate while maintaining an undifferentiated state, and can differentiate 
into at least one phenotype. Adult, or somatic, stem cells are maintained 
throughout life to renew and repair the local tissues. There are several 
different varieties of adult stem cells, which include mesenchymal stem 
cells (MSCs), hematopoietic stem cells, and neural stem cells. Multipotent 
adult stem cells (MASCs) are distinct from MSCs as undifferentiated cells 
found in several tissues in post-natal animals. They are able to generate 
progeny of several distinct cell types of all three dermal lineages, and have 
an apparent unlimited proliferation potential. Their differentiation is 
determined by local cues. To date, very little is known about the gene 
expression profile of MASCs.  Since bone marrow-derived MSCs were first 
experimentally expanded and differentiated through 4 mesodermal 
lineages in the 1990’s1, MSCs have been the subject of investigation due to 
their relative accessibility and supposed regenerative potential. Despite the 
wealth of knowledge these studies have provided, the exact nature of the 
relationship between MSCs and MASCs remains to be elucidated.  
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CONCLUSIONS 
The 6 developmental pathways listed below provide clues to explain 
the wide differentiation potential of MASCs; they uniquely express 
genes important for the early progression of these pathways. In 
addition to epiregulin, the genes involved in germline development 
may provide insight into the apparent unlimited proliferation potential 
of MASCs. Future studies will include a comparison of gene 
expression profiles between HfSCs and human ESCs, and between 
HfSCs and human differentiated cells, specifically smooth muscle 
cells. 
 
The BM-MSC mRNA expression does not conform to the ISCT 
standards, or other common MSC cellular markers. That the PL-
MSCs do not conform to certain MSC cellular markers either, 
indicates that current protein and gene expression criteria for defining 
adult stem cells may be inadequate as they currently stand. RESULTS 
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Minimal criteria set by the International Society for Cellular Therapy 
Dominici M, Le Blanc K, Horwitz E, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The 
International Society for Cellular Therapy position statement. Cytotherapy (Taylor & Francis Ltd). August 2006;8 
(4):315-317.      
       Other criteria:  
Ravenska Wagey.  Mini-Review Mesenchymal Cells.  STEMCELL Technologies Inc. www.STEMCELL.com;(2011).  
 
ISCT Criteria BM-MSC PL-MSC HfSC 
Plastic Adherent + + + 
CD73+ + + + 
CD90+ + + + 
CD105+ + + + 
CD11b- - - - 
CD14- + - - 
CD19- - - - 
CD34- - - - 
CD45- - - - 
HLA-DR- + - - 
Other Criteria BM-MSC PL-MSC HfSC 
CD106 (VCAM1)+ + - - 
CD117 (KIT)- - + + 
CD271 (NGFR)+ - + - 
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